Charité - Universitätsmedizin Berlin
Neuroblastoma treatment cost in Germany generally runs between $90,000 and $155,000 for comprehensive therapeutic protocols. Essential diagnostics like a consultation with an oncologist range from $300 to $500. Total expenses depend on the cancer stage, required radiotherapy, and hospital tier. International patients often save around 40% compared to US medical rates. Berlin, Hamburg, and Dusseldorf are the primary treatment hubs.
Typical Neuroblastoma Treatment Costs in Germany
Bookimed Expert Insight: Advanced cases requiring high-tech interventions benefit from large university centers. Charité - Universitätsmedizin Berlin utilizes AI and robotic surgery for complex pediatric oncology. Patients seeking established expertise should consider Asklepios Nord Clinic, a Focus-ranked facility in Hamburg. For specialized neurosurgical tumor removal, Professor Jürgen Kiwit in Berlin offers over 25 years of experience. This combination of academic research and clinical experience ensures high standards for international families.
| Germany | Turkey | Austria | |
| Complex treatment of neuroblastoma | from $90,000 | from $28,000 | from $180,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Neuroblastoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Neuroblastoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Neuroblastoma treatment journey.
Prof. Jürgen Kiwit is a top German neurosurgeon with over 35 years of experience of experience and specializes in brain and spinal cord tumors at Meoclinic Berlin.
Head of the Department of Pediatric Oncology at the prestigious Charité hospital – Europe's largest university hospital.
German pediatric oncology centers utilize standardized, multi-phase multimodal protocols coordinated by the German Society for Pediatric Oncology and Hematology. These include high-dose chemotherapy followed by autologous stem cell transplantation and anti-GD2 immunotherapy. Advanced centers like Charité Universitätsmedizin Berlin integrate 131I-mIBG therapy for refractory cases.
Bookimed Expert Insight: Germany maintains a highly organized infrastructure with 82 specialized clinics. Large university hospitals like Charité - Universitätsmedizin Berlin manage over 5,000 pediatric cases annually. This high volume allows departments led by experts like Dr. Angelika Eggert to refine complex CAR NK cell therapies. Such specialization ensures patients receive care that meets the strict German Cancer Society standards.
Patient Consensus: Patients note that high-risk care is concentrated in university hospitals with specialized pediatric teams. They emphasize the importance of monitoring side effects like hearing loss and neuropathy during intensive immunotherapy cycles.
Germany hosts several clinical trials for relapsed or high-risk neuroblastoma. Major academic centers participate in the BEACON2 and HR-NBL2 (SIOPEN) trials. These programs evaluate new drug combinations and immunotherapies. Patients often access these through university hospitals certified by the German Cancer Society.
Bookimed Expert Insight: While many countries offer standard care, Germany stands out for precision medicine registries like INFORM. Charité Berlin, an institution with 100 departments and over 4,000 doctors, serves as a major hub for these registries. This large patient volume often means faster accrual for early-phase drug trials compared to smaller regional centers.
Patient Consensus: Parents note that finding the right study depends on specific molecular testing. They emphasize having pathology and imaging results ready early to meet strict enrollment windows for relapsed disease protocols.